Lyka Labs Limited (LYKALABS) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.135x

Based on the latest financial reports, Lyka Labs Limited (LYKALABS) has a cash flow conversion efficiency ratio of 0.135x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs136.84 Million ≈ $1.48 Million USD) by net assets (Rs1.01 Billion ≈ $10.96 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See LYKALABS equity financing ratio to measure how much of total assets are equity-financed.

Lyka Labs Limited - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Lyka Labs Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check LYKALABS operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Lyka Labs Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Lyka Labs Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Korean Drug Co. Ltd KQ:014570	0.080x
Coal Energy S.A. WAR:CLE	0.360x
FSBM Holdings Bhd KLSE:9377	-0.040x
Indo Acidatama Tbk JK:SRSN	0.060x
Actuate Therapeutics, Inc. Common stock NASDAQ:ACTU	-0.611x
A SPAC III Acquisition Corp. Class A Ordinary Shares NASDAQ:ASPC	-0.056x
FIGENE CAPITAL SA ZY 1 F:20X	N/A
eMnet Inc KQ:123570	-0.022x

Annual Cash Flow Conversion Efficiency for Lyka Labs Limited (2005–2025)

The table below shows the annual cash flow conversion efficiency of Lyka Labs Limited from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see Lyka Labs Limited (LYKALABS) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs1.04 Billion ≈ $11.20 Million	Rs18.99 Million ≈ $205.41K	0.018x	-29.41%
2024-03-31	Rs682.65 Million ≈ $7.38 Million	Rs17.73 Million ≈ $191.78K	0.026x	-86.75%
2023-03-31	Rs456.71 Million ≈ $4.94 Million	Rs89.53 Million ≈ $968.19K	0.196x	-96.66%
2022-03-31	Rs134.91 Million ≈ $1.46 Million	Rs792.46 Million ≈ $8.57 Million	5.874x	+1772.76%
2021-03-31	Rs-250.93 Million ≈ $-2.71 Million	Rs88.11 Million ≈ $952.93K	-0.351x	+0.32%
2020-03-31	Rs-151.11 Million ≈ $-1.63 Million	Rs53.23 Million ≈ $575.71K	-0.352x	-160.45%
2019-03-31	Rs457.59 Million ≈ $4.95 Million	Rs266.66 Million ≈ $2.88 Million	0.583x	+211.82%
2018-03-31	Rs582.36 Million ≈ $6.30 Million	Rs108.83 Million ≈ $1.18 Million	0.187x	-74.93%
2017-03-31	Rs421.01 Million ≈ $4.55 Million	Rs313.81 Million ≈ $3.39 Million	0.745x	+1938.60%
2016-03-31	Rs491.54 Million ≈ $5.32 Million	Rs-19.93 Million ≈ $-215.50K	-0.041x	-107.11%
2015-03-31	Rs465.71 Million ≈ $5.04 Million	Rs265.40 Million ≈ $2.87 Million	0.570x	-64.17%
2014-03-31	Rs560.17 Million ≈ $6.06 Million	Rs890.99 Million ≈ $9.64 Million	1.591x	+914.04%
2013-03-31	Rs697.62 Million ≈ $7.54 Million	Rs109.43 Million ≈ $1.18 Million	0.157x	+154.43%
2012-03-31	Rs755.73 Million ≈ $8.17 Million	Rs-217.78 Million ≈ $-2.36 Million	-0.288x	-380.89%
2010-03-31	Rs1.43 Billion ≈ $15.41 Million	Rs146.23 Million ≈ $1.58 Million	0.103x	+129.68%
2008-03-31	Rs780.73 Million ≈ $8.44 Million	Rs-269.87 Million ≈ $-2.92 Million	-0.346x	-33.00%
2007-03-31	Rs460.74 Million ≈ $4.98 Million	Rs-119.75 Million ≈ $-1.29 Million	-0.260x	-136.00%
2005-03-31	Rs286.25 Million ≈ $3.10 Million	Rs206.68 Million ≈ $2.24 Million	0.722x	--

About Lyka Labs Limited

NSE:LYKALABS India Biotechnology

Market Cap

$24.64 Million

Rs2.28 Billion INR

Market Cap Rank

#24377 Global

#1354 in India

Share Price

Rs63.84

Change (1 day)

+5.00%

52-Week Range

Rs44.95 - Rs108.99

All Time High

Rs254.30